Europe:+32-2-535-7543
Asia: +65-6223-2436
Int'l: +1-860-674-8796
US: +1-866-353-3335
  • Chinese
Cover Image

2015 Strategies in the German Nucleic Acid Testing Market

Comprehensive 1,125-page market segmentation analysis of the German NAT market.

Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.

Table of Contents

Introduction

Worldwide Market And Technology Overview

A. DNA Sequencing

  • 1. Introduction
  • 2. Sequencing Methods
  • 3. Autoradiography
  • 4. The Human Genome Project
  • 5. Sequencing Automation
  • 6. Image Scanners
  • 7. Fluorescent Detection
  • 8. Gene Profiling
  • 9. Gene Expression
  • 10. Polymorphism Screening
  • 11. Protein Interaction Networks

B. DNA And RNA Probe Technology

  • 1. Basic Principles
  • 2. Probe Preparation
  • 3. The DNA Probe Test
    • a. Sample Preparation
    • b. Hybridization
    • c. Separation
    • d. Detection/Measurement
  • 4. Test Formats
    • a. Filter Hybridization
    • b. Southern Blot
    • c. Northern Blot
    • d. In Situ Hybridization
    • e. Others
  • 5. Labeling Techniques
  • 6. Amplification Methods
    • Polymerase Chain Reaction
      • Temperature Cyclers
      • PCR Variations
        • Immuno-PCR
        • QC-PCR
        • DAP-PCR
    • Strand Displacement Activation
    • TMA
    • Ligase Chain Reaction
    • Branched DNA
      • Hybridization Protection Assay
    • Nucleic-Acid Sequence-Based Amplification
    • Self-Sustained Sequence Replicase
    • Others
      • Ampliprobe
      • CAR
      • CAS
      • CPT
      • Dendritic Polymer Technology
      • ISO-CR
      • LAT
      • Probe Networks
      • RAMP
      • Repair Chain Reaction
      • Rolling Circles
      • Sequence Independent Gene Amplification
      • Sequence Initiation Reaction
      • SISPA
      • Solid Phase Amplification

C. Detection Technologies

  • 1. Radioactive Methods
    • a. Overview
    • b. Major Isotopes
      • P-32
      • S-35
      • H-3
      • I-125
  • 2. Non-Isotopic Methods
    • a. Enzymatic Labels
    • b. Chemical Labeling
      • Indirect Chemical Labeling
      • Direct Chemical Labeling
    • c. Fluorescence
    • d. Chemiluminescence
    • e. Electrical Conductivity

D. Instrumentation Review

  • 1. Abbott LCx
  • 2. Beckman Coulter/Biomek FK
  • 3. Becton Dickinson SDA
  • 4. Bio-Rad GeneScope
  • 5. Gen-Probe Tigris
  • 6. Roche Cobas Amplicor
  • 7. Tecan LS Series

E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

  • Liquid Transportation and Mixing
  • Separation
  • Reaction
  • Detection

F. Pharmacogenomics

G. Major Applications

1. Microbiology/Infectious Diseases

  • a. Overview
  • b. Major Infectious Diseases
  • * AIDS
    • Structure and Composition
    • Classification
    • AIDS Origins
    • Animal Lentivirus Systems
    • Virus Receptors
    • HIV Infections in Humans
      • Pathogenesis and Pathology
    • CD4T Lymphocytes and Memory Cells
    • Monocytes and Macrophages
    • Lymphoid Organs
    • Neural Cells
    • Viral Coinfections
      • Clinical Findings
    • Plasma Viral Load
    • Table of Contents (continued)
    • Pediatric AIDS
      • Neurologic Disease
      • Opportunistic Infections
      • Cancer
    • Immunity
      • Virus Isolation
      • Serology
      • Viral Nucleic Acid/Antigen Detection
    • Epidemiology
      • Worldwide Spread of AIDS
      • United States
      • Routes of Transmission
    • DNA Probes
      • Overview
      • Quantitative PCR
      • In Situ PCR
      • Needed Improvements
    • Viral Load/Drug Resistance Testing
    • Genotype and Phenotype Testing
    • Blood Banking Considerations
  • * Adenovirus
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
    • Adeno-Associated Viruses (AAV)
  • * Anthrax/Bacillus Anthracis
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Babesiosis
    • Background
  • * BEA and Other Bartonella Diseases
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Chagas Disease
    • Background
    • Table of Contents (continued)
  • * Campylobacter
    • Background
    • Diagnostic Tests
      • Culture Identification
    • Vaccines and Drugs
  • * Chlamydia
    • Background
      • Chlamydia psittaci
      • Chlmaydia pneumoniae
      • Chlamydia trachomatis
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Creutzfeldt-Jakob's Disease
    • Background
    • Blood Transmission
    • Diagnostic Tests
    • Major Commercial and Academic Players
      • Bayer
      • Disease Sciences/Bio Tec Global
      • Imperial College School of Medicine
      • Ortho-Clinical Diagnostics
      • Pall
      • ProMetic Life Sciences
      • Proteome Sciences/Idexx
      • Q-One Biotech
      • Serono
      • U.S. Agricultural Research Service
    • Drugs
    • Vaccines
  • * Cytomegalovirus
    • Background
      • Chorioretinitis
      • Gastrointestinal
      • Central Nervous System Disease
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Ebola Virus
    • Background
      • Epidemiology
      • Clinical Syndromes
    • Table of Contents (continued)
    • Diagnostic Tests
    • Vaccines and Drugs
  • * EchoVirus
    • Background
      • Acute Aseptic Meningitisis
      • Encephalitis
      • Exanthems
      • Respiratory Disease
      • Myopericarditis
      • Neonatal Infections
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Encephalitis
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Enteroviruses
    • Background
    • Diagnostic Tests
      • Viral Isolation and Identification
      • Antibody Tests
    • Vaccines and Drugs
  • * Epstein-Barr Virus
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Gonorrhea
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Hepatitis
    • Hepatitis A
    • Hepatitis B
      • Structure and Composition
      • Replication
    • Hepatitis C
    • Hepatitis D (Delta)
    • Hepatitis E
    • Hepatitis G
    • Hepatitis Infections Pathology
    • Clinical Findings
    • Laboratory Tests
    • Table of Contents (continued)
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Hepatitis D
      • Hepatitis E
    • Virus-Host Immune Reactions
    • Epidemiology
      • Hepatitis A
      • Hepatitis B
      • Hepatitis C
      • Hepatitis D (Delta)
    • Vaccines and Drugs
  • * Herpes Simplex Virus
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Legionella
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Lyme Disease
    • Background
      • Clinical Description
      • Clinical Case Definition
      • Laboratory Criteria for Diagnosis
      • Case Classification
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Malaria
  • * Mycoplasma
    • Background
      • Ureaplasma Urealyticum & Mycoplasma
    • Hominis
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Papillomaviruses/HPV
    • Background
      • HPV in Cancer
      • Cervical Neoplasm
    • Diagnostic Tests
    • Vaccines and Drugs
    • Table of Contents (continued)
      • Prevention
  • * Parvovirus B19
    • Background
      • Microbiology
      • Epidemiology
      • Clinical Syndromes
      • Erythema Infectiosum (Slapped Cheek)
      • Adult Polyarthropathy
      • Transient Aplastic Crisis
      • Transient Pancytopenia
      • Red Cell Aplasia in Immunocompromised
      • Perinatal Infections
    • Diagnostic Test
    • Vaccines and Drugs
  • * Pneumonia
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Polyomaviruses
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Salmonellosis
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Shigellosis
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Streptococci
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
      • Group A Streptococci
      • Group B Streptococci
  • * Toxoplasmosis
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
    • Table of Contents (continued)
  • * Tuberculosis
    • Background
    • Diagnostic Tests
      • Microscopic Characteristics
      • Cultural Characteristics
      • Skin Tests
      • MDRTB
    • Vaccines and Drugs
  • * West Nile Virus
    • Background
      • Clinical Syndromes
    • Diagnostic Tests
    • Vaccines and Drugs
  • * Yersinia
    • Background
    • Diagnostic Tests
    • Vaccines and Drugs
    • c. Antibiotic Susceptibility

2. Cancer Testing

  • a. Overview
  • b. Major Cancer Types
  • * Prostate
  • * Lung
  • * Colon and Rectum
  • * Breast
  • * Skin
  • * Uterine
  • * Leukemia
  • * Oral
  • c. Oncogenes
    • Abl/abl-bcr
    • AIB1
    • BCL-2
    • BRCA1
    • CD44
    • C-fos
    • C-myb
    • C-myc
    • CYP17
    • Erb-B
    • HPC1
    • N-myc
    • P40
    • P51
    • P53
    • PIK3CA
    • PTI-1
    • Ras
    • Reg
    • Sis
    • Src

3. Genetic Diseases

  • a. Overview
  • b. Nucleic Acid Amplification
  • c. Chromosome Imaging
  • d. Genomics Technologies
  • e. Proteomics Technologies
  • f. Current Pharmacogenomic Tests
  • g. Future Pharmacogenomic Testing
  • h. Major Diseases
    • * Achondroplasia
    • * Autosomal Dominant Polycystic Kidney Disease
    • * Cancer
    • * Cosmetogenomics
    • * Cystic Fibrosis
    • * Down's Syndrome
    • * Duchenne and Becker Muscular Dystrophy
    • * Factor V (Leiden)
    • * Factor IX Deficiency
    • * Fragile X Syndrome
    • * Heart Disease
    • * Hemochomatosis
    • * Hemophilia
    • * Huntington's Disease
    • * Maternal-Fetal Incompatibility
    • * Multiple Endocrine Neoplasia
    • * Phenylketonuria (PKU)
    • * Polycystic Kidney Disease (PKD)
    • * Prenatal Screening
    • * Retinitis Pigmentosa
    • * Retinoblastoma
    • * Sickle Cell Anemia
    • * Spinal Muscular Atrophy
    • * Vitamin B12 Metabolism
  • i. Social Issues and Concerns

4. Forensic Testing

  • a. Overview
  • b. Multilocus and Single Locus Probes
    • * Multilocus Probes
    • * Single Locus Probes
    • * PCR and RFLP
  • c. The FBI
  • d. DNA Profile Data Banks
    • * U.S.A.
    • * U.K.
  • e. Judicial Implementation
  • f. Major Crime Categories
  • g. Factors Contributing to the DNA Probe Market Expansion
    • * Technology Availability
    • * Use of Hair as Evidence
  • h. Wildlife Forensics

5. Paternity Testing/HLA Typing

6. Other Applications

  • a. Disease Susceptibility Testing
  • b. Cardiovascular Diseases
  • c. Diabetes
  • d. Alzheimer's Disease
  • e. Periodontal Disease
  • f. Plasma Purification
  • g. Organ Transplantation
  • h. Water Contamination
  • i. Other

H. Competing/complementing Technologies

  • 1. Monoclonal Antibodies/Immunoassays
  • 2. RNA Probes
  • 3. Two-Dimensional Electrophoresis
  • 4. Flow Cytometry

I. Worldwide Market Overview

  • 1. Business Environment
  • 2. Market Structure
  • 3. Market Size and Growth

Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth And Major Suppliers'Sales And Market Shares

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies For Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types Of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers And Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Profiles

  • Abbott
  • Affymetrix
  • Agilent
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Hologic
  • Illumina
  • Innogenetics/Solvay
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

Appendixes

  • Appendix I: Major Universities and Research Centers Developing NAT Technology
  • Appendix II: Glossary of Terms
  • Appendix III: Currency Exchange Rates

List of Tables

  • Major Companies Developing or Marketing AIDS NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme Disease NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Papilloma Virus NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis NAT And Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis NAT And Other Direct Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis Major Companies Developing or Marketing Cancer NAT Tests
  • Major Companies Developing or Marketing NAT Assays For Genetic Diseases
  • Summary Table Germany, NAT Test Volume And Sales Forecast by Major Application
  • Germany, Laboratories Performing DNA Sequencing by Market Segment
  • Germany, NAT Market Potential Laboratory Universe by Market Segment
  • Germany, NAT Test Volume Forecast By Major Application
  • Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • Germany, Infectious Disease Screening NAT Volume Forecast
  • Germany, NAT Market Forecast By Major Application Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
  • Germany, NAT Market by Major Supplier
  • Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Show More
RELATED REPORTS
* 2015 Strategies in the Global Nucleic Acid Testing Market
  • Published:
  • May 13, 2015
  • USD 15900
  • 1398 Pages

* 2015 Strategies in the Japanese Nucleic Acid Testing Market
  • Published:
  • May 13, 2015
  • USD 5500
  • 1126 Pages

* 2015 Strategies in the UK Nucleic Acid Testing Market
  • Published:
  • May 13, 2015
  • USD 4300
  • 1122 Pages

* 2015 Strategies in the US Nucleic Acid Testing Market
  • Published:
  • May 13, 2015
  • USD 6200
  • 1157 Pages

* Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing & Other TB Tests) Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020
  • Published:
  • Mar 23, 2015
  • USD 4795
  • 109 Pages

* Blood Screening Market by Technology (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting), Product (Instrument, Reagent) & End User (Blood Bank, Hospital) - Forecasts to 2019
  • Published:
  • Mar 11, 2015
  • USD 4650
  • 206 Pages

* 2015 Analysis of Emerging Nucleic Acid Testing Assays, and Strategic Profiles of Leading Suppliers
  • Published:
  • Jan 23, 2015
  • USD 3500
  • 549 Pages

* 2015 Global Nucleic Acid Testing (NAT) Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
  • Published:
  • Jan 23, 2015
  • USD 3500
  • 109 Pages

* 2014-2018 Japanese Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
  • Published:
  • Nov 12, 2014
  • USD 5500
  • 860 Pages

* 2014-2018 US Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
  • Published:
  • Nov 12, 2014
  • USD 6200
  • 880 Pages

Browse more In Vitro Diagnostics Market Research Reports

Pricing
Back to Top